Donepezil Pellets

(Product under development)
Donepezil PelletsDonepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor.

Its main therapeutic use is in the palliative treatment of mild to moderate Alzheimer's disease. Common side effects include gastrointestinal upset.

It has an oral bioavailability of 100% and easily crosses the blood-brain barrier. Because it has a half-life of about 70 hours, it can be taken once a day.

Available Forms:
Donepezil Pellets
Donepezil Granulers

Umang Pharmatech equipments used for production of Donepezil Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Donepezil Pellets
Systematic (IUPAC) name
Donepezil Pellets
Identifiers
Donepezil Pellets
Chemical data
(RS)-2-[(1-benzyl-4-piperidyl)methyl]- 5,6-dimethoxy-2,3-dihydroinden-1-one
CAS number : 120014-06-4
ATC code : N06DA02
PubChem : CID 3152
DrugBank : APRD00039
ChemSpider : 3040
UNII : 8SSC91326P
KEGG : D07869
ChEBI : CHEBI:53289
ChEMBL : CHEMBL502
Formula : C24H29NO3
Mol. mass : 379.492 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL